Renal Cancers Completed Phase 2 Trials for Sargramostim (DB00020)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00514215Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung CancerTreatment
NCT00002475Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerTreatment
NCT00003408Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerTreatment
NCT00006483Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the LungTreatment
NCT00090870PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney CancerTreatment